PubRank

Erythropoietin in Traumatic Brain Injury (EPO-TBI) (EPO-TBI)

Clinical Trial ID NCT00987454

PubWeight™ 15.24‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00987454

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs 2010 1.67
2 Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. Lancet 2015 1.60
3 Erythropoietin (EPO) in acute kidney injury. Ann Intensive Care 2011 1.51
4 Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup. J Neurotrauma 2014 1.31
5 Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats. J Neurosurg 2011 1.10
6 Neurorestorative treatments for traumatic brain injury. Discov Med 2010 0.94
7 Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward? J Investig Med 2011 0.92
8 Erythropoietin as a novel brain and kidney protective agent. Anaesth Intensive Care 2011 0.91
9 Beyond intracranial pressure: optimization of cerebral blood flow, oxygen, and substrate delivery after traumatic brain injury. Ann Intensive Care 2013 0.89
10 Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial. Trials 2015 0.87
11 Investigational agents for treatment of traumatic brain injury. Expert Opin Investig Drugs 2015 0.84
12 Erythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury. J Neurotrauma 2014 0.80
13 Erythropoietin in the neurology ICU. Curr Treat Options Neurol 2013 0.76
14 Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury. Trials 2014 0.76
15 A State-of-the-Science Overview of Randomized Controlled Trials Evaluating Acute Management of Moderate-to-Severe Traumatic Brain Injury. J Neurotrauma 2016 0.75
Next 100